<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03568591</url>
  </required_header>
  <id_info>
    <org_study_id>LMT1131992C</org_study_id>
    <nct_id>NCT03568591</nct_id>
  </id_info>
  <brief_title>The Efficacy of a Psychosomatic Intervention</brief_title>
  <official_title>A Parallel-Group Controlled Trial Examining the Efficacy of a Psychosomatic Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiff Metropolitan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of East Anglia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardiff Metropolitan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines the efficacy of a psychosensory intervention in relation to: Resilience,
      Type D personality, and physiological effects (on blood pressure, heart rate and salivary
      cortisol) in a group of people who have self-referred for the trauma resolution psychosensory
      therapy - Havening Techniques (HT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study utilizes a single blind (researcher blind) comparison of the psychosensory therapy
      Havening Techniques (treatment) versus waiting list (no treatment). Participants will be
      assessed using resilience testing (CD-RISC), and Type D measure of personality (DS14). A
      subgroup of the treatment arm will be assessed for the biomarkers of blood pressure, heart
      rate and cortisol. This parallel-group controlled trial will examine the efficacy of Havening
      Techniques at 3 timepoints; baseline (Time point 1), twenty-four hours post (Time point 2)
      and one month later (Time point 3).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 11, 2016</start_date>
  <completion_date type="Actual">November 1, 2016</completion_date>
  <primary_completion_date type="Actual">October 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A researcher-blind parallel-group controlled psychosomatic therapy intervention trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Coded-analysis group allocation and database - blind to allocation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from the baseline DS14 measure of Type D personality scores at time point 2.</measure>
    <time_frame>24 hours post intervention (Time point 2) versus pre-intervention (Time point 1)</time_frame>
    <description>Co-primary outcome measure: The DS14 measure of Type D personality is a 14-item questionnaire that uses a 5-point likert scale, each item weighted from 0 to 4. The DS14 incorporates the two 7-item subscales measuring the negative affect and social inhibition constituents of Type D personality (Denollet, 2005).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from the baseline Connor-Davidson Resilience Scale (CD-RISC) scores at time point 2.</measure>
    <time_frame>24 hours post intervention (Time point 2) versus pre-intervention (Time point 1)</time_frame>
    <description>Co-primary outcome measure: The Connor-Davidson Resilience Scale (CD-RISC) assesses resilience and constitutes a 25=item questionnaire scored on a 5-point likert scale (rated 0-4). This scale has been successfully applied to evaluate change in intervention studies targeted at resilience (Connor and Davidson, 2003).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the DS14 measure of Type D personality score at time point 3.</measure>
    <time_frame>1 month post intervention (Time point 3)</time_frame>
    <description>Repeat assessment of co-primary outcome measure 1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Connor-Davidson Resilience Scale (CD-RISC) score at time point 3.</measure>
    <time_frame>1 month post intervention (Time point 3)</time_frame>
    <description>Repeat assessment of co-primary outcome measure 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Systolic Blood Pressure from baseline to time point 2.</measure>
    <time_frame>24 hours post intervention (Time point 2) versus pre-intervention (Time point 1)</time_frame>
    <description>Systolic blood pressure will be assessed following rest in a sitting position (using an Omron hem 722c device).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Systolic Blood Pressure at time point 3.</measure>
    <time_frame>1 month post intervention (Time point 3)</time_frame>
    <description>Systolic blood pressure will be assessed following rest in a sitting position (using an Omron hem 722c device).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Diastolic Blood Pressure from baseline to time point 2.</measure>
    <time_frame>24 hours post intervention (Time point 2) versus pre-intervention (Time point 1)</time_frame>
    <description>Diastolic blood pressure and heart rate will be assessed following rest in a sitting position (using an Omron hem 722c device).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Diastolic Blood Pressure at time point 3.</measure>
    <time_frame>1 month post intervention (Time point 3)</time_frame>
    <description>Diastolic blood pressure and heart rate will be assessed following rest in a sitting position (using an Omron hem 722c device).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate from baseline to time point 2.</measure>
    <time_frame>24 hours post intervention (Time point 2) versus pre-intervention (Time point 1)</time_frame>
    <description>Heart rate will be assessed following rest in a sitting position (using an Omron hem 722c device).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Heart Rate at time point 3.</measure>
    <time_frame>1 month post intervention (Time point 3)</time_frame>
    <description>Heart rate will be assessed following rest in a sitting position (using an Omron hem 722c device).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Salivary Cortisol levels from baseline to time point 2.</measure>
    <time_frame>24 hours post intervention (Time point 2) versus pre-intervention (Time point 1)</time_frame>
    <description>Salivette recordings taken at identical times of day (to avoid circadian influences) following rest in a sitting position. Dietary consistency and avoidance of alcohol advised to avoid confounding variables. Samples to be analysed by the clinical laboratory.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Salivary Cortisol Levels at time point 3.</measure>
    <time_frame>1 month post intervention (Time point 3)</time_frame>
    <description>Salivette recordings taken at identical times of day (to avoid circadian influences) following rest in a sitting position. Dietary consistency and avoidance of alcohol advised to avoid confounding variables. Samples to be analysed by the clinical laboratory.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Type D Personality</condition>
  <condition>Trauma, Psychological</condition>
  <arm_group>
    <arm_group_label>Intervention Group (Treatment)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A treatment group cohort who have self-referred for the psychosensory therapy intervention (Havening Techniques).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group (Waiting List)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Self-referral waiting list cohort (usual care).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Psychosensory Therapy</intervention_name>
    <description>Havening Techniques are a psychosensory therapy that incorporate the application of sensory input to alter neurochemical responses influencing thought, emotion and behaviour (Ruden, 2011).</description>
    <arm_group_label>Intervention Group (Treatment)</arm_group_label>
    <other_name>Havening Techniques</other_name>
    <other_name>Psychosomatic Intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to provide informed consent.

          -  Cognisant adults living in the United Kingdom.

          -  Will have self-referred for Havening Techniques trauma therapy.

        Exclusion Criteria:

          -  Receiving any other therapeutic or pharmaceutical intervention in parallel.

          -  For the psychobiological evaluation subgroup: a history of HIV, Tuberculosis or
             Hepatitis B due to laboratory regulations.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirsty Hodgson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Psychology Department, Cardiff Metropolitan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Psychology Department</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF5 2YB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://www.routledge.com/When-the-Past-Is-Always-Present-Emotional-Traumatization-Causes-and/Ruden/p/book/9780415875646</url>
    <description>Ruden, R. (2011) When the Past is Always Present - Emotional Traumatisation, Causes, and Cures. USA: Routledge.</description>
  </link>
  <reference>
    <citation>Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005 Jan-Feb;67(1):89-97.</citation>
    <PMID>15673629</PMID>
  </reference>
  <reference>
    <citation>Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76-82.</citation>
    <PMID>12964174</PMID>
  </reference>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>May 21, 2018</study_first_submitted>
  <study_first_submitted_qc>June 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2018</study_first_posted>
  <last_update_submitted>June 14, 2018</last_update_submitted>
  <last_update_submitted_qc>June 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiff Metropolitan University</investigator_affiliation>
    <investigator_full_name>Kirsty Hodgson</investigator_full_name>
    <investigator_title>Principal Investigator - Research Lead</investigator_title>
  </responsible_party>
  <keyword>Psychosensory Therapy</keyword>
  <keyword>Trauma, Psychological</keyword>
  <keyword>DS14</keyword>
  <keyword>CD-RISC</keyword>
  <keyword>Resilience</keyword>
  <keyword>Psychosomatic Medicine</keyword>
  <keyword>Type D Personality</keyword>
  <keyword>Salivary Cortisol</keyword>
  <keyword>Blood Pressure</keyword>
  <keyword>Havening Techniques</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psychological Trauma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

